US Stocks
/
Outlook Therapeutics, Inc. Share Price
Outlook Therapeutics, Inc. Share Price

Outlook Therapeutics, Inc. Share Price

NASDAQ: OTLK | Micro Cap
$0.60
+$0.04 (7.52%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Outlook Therapeutics, Inc. Stock Performance

Open
$0.57
Prev. Close
$0.56
Circuit Range
N/A
Day Range
$0.56 - $0.60
Year Range
$0.16 - $2.51
Volume
66,963
Average Traded
$0.59

Outlook Therapeutics, Inc. Share Price Today

As of 10 October 2026, Outlook Therapeutics, Inc.'s share price is $0.60. The stock opened at $0.57, compared to its previous close of $0.56. During today's trading session, Outlook Therapeutics, Inc.'s share price traded between $0.56 and $0.60, with an average price of $0.58. Over the past 52 weeks, the stock has recorded a high of $2.51 and a low of $0.16. In terms of performance, Outlook Therapeutics, Inc.'s share price has risen by 137.47% over the last six months and is down 52.69% on a year-on-year basis.

Outlook Therapeutics, Inc. Share Price Chart

$0.56$0.60
L
Show Current Price
H

Outlook Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$20.91M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.20
Revenue (TTM)
$1.41B
Return On Equity (TTM)
460.24%
Profit Margin
-4426.95%
Debt to Equity
-1.75
Quarterly Earnings Growth YoY
N/A

Outlook Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
RevenueN/A-$1.21$0.13$0.01
Net ProfitN/A-$23.06-$4.45-$20.32
Net Profit MarginN/A1905.79%-3423.08%-203200.00%
Income ChangeN/AN/A80.70%-356.63%

Outlook Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$1.41
Net Profit-$66.05-$58.98-$75.37-$62.42
Net Profit MarginN/AN/AN/A-4426.95%
Income ChangeN/A10.70%-27.79%17.18%

About Outlook Therapeutics, Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Outlook Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.56
$0.60
+3.80%
Sep 2026
$0.63
$0.58
-9.67%
Aug 2026
$0.94
$0.64
-34.46%
Jul 2026
$1.49
$0.98
-38.88%
Jun 2026
$0.74
$1.60
+119.48%
May 2026
$0.26
$0.73
+188.14%
Apr 2026
$0.21
$0.25
+25.87%
Mar 2026
$0.43
$0.20
-52.48%
Feb 2026
$0.43
$0.42
-3.20%
Jan 2026
$0.64
$0.44
-72.34%
Dec 2025
$1.79
$1.58
-11.98%
Nov 2025
$1.27
$1.79
+41.34%

OTLK Share Price FAQs

What is Outlook Therapeutics, Inc. share price today?

chevron-up
Outlook Therapeutics, Inc. share price today is $0.60 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Outlook Therapeutics, Inc. stock?

chevron-up
The 52 week high of Outlook Therapeutics, Inc. stock is $2.51, while the 52 week low is $0.16 as of 10 Oct '26.

What is OTLK's market capitalisation today?

chevron-up
OTLK market capitalisation is $20.91M as of October 10, 2026, at 3:12 pm IST.

What is OTLK's net income for the last quarter?

chevron-up
OTLK's net income for the last quarter is -20.32B USD.

What is the 5 year returns of OTLK?

chevron-up
The 5 year returns of OTLK is -98.55% as on 10 Oct '26.

What is the high & low stock price of OTLK today?

chevron-up
OTLK stock price hit a high of $0.60 and low of $0.56 as of 10 Oct '26.

Can I buy OTLK shares in India?

chevron-up
Yes. You can buy OTLK in India by opening an international trading account.